Mucopolysaccharidosis type II (MPS II): Evaluate of food intakes in patients on enzyme replacement therapy

被引：0
|
作者：
Oliveira, R. B. [1 ]
Frangipani, B. J. [1 ]
Lauandos, J. R. [1 ]
Micheletti, C. [1 ]
Silveira, M. T. [1 ]
Vertemati, T. [1 ]
Martins, A. M. [1 ]
机构：
[1] CREIM UNIFESP, Sao Paulo, Brazil
来源：
JOURNAL OF INHERITED METABOLIC DISEASE | 2008年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
397P
引用
收藏
页码：100 / 100
页数：1
相关论文
共 50 条
  • [41] Enzyme replacement therapy for mucopolysaccharidosis type II: Experience from a Brazilian reference center
    Curiati, Marco A.
    Mendes, Carmen Silvia C.
    Rand, Maret H.
    Canossa, Sueli
    Goncalves, Cintia M.
    Silva, Rosangela M.
    Silva, Jose
    Oliveira, Renata B.
    Kyosen, Sandra O.
    Aranda, Carolina S.
    Martins, Ana Maria
    MOLECULAR GENETICS AND METABOLISM, 2015, 114 (02) : S34 - S35
  • [42] Auditory Characteristics and Therapeutic Effects of Enzyme Replacement in Mouse Model of the Mucopolysaccharidosis (MPS) II
    Hong, Sung Hwa
    Chu, Hosuk
    Kim, Ki Ryung
    Ko, Moon Hee
    Kwon, See Youn
    Moon, Il Joon
    Chung, Won-Ho
    Cho, Yang-Sun
    Kim, Chi-Hwa
    Suh, Myung-Whan
    Choi, Eun Wha
    Sohn, Young Bae
    Park, Sung Won
    Kim, Se-Hwa
    Cho, Sung-Yoon
    Ko, Ah-Ra
    Jin, Dong-Kyu
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2012, 158A (09) : 2131 - 2138
  • [43] Mucopolysaccharidosis: Cardiologic features and effects of enzyme-replacement therapy in 24 children with MPS I, II and VI
    Brands, Marion M. M. G.
    Frohn-Mulder, Ingrid M.
    Hagemans, Marloes L. C.
    Hop, Wim C. J.
    Oussoren, Esmee
    Helbing, Wim A.
    van der Ploeg, Ans T.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2013, 36 (02) : 227 - 234
  • [44] Effect of enzyme replacement therapy on sleep-disordered breathing in type II mucopolysaccharidosis
    D'Cruz, OF
    Vaughn, B
    Muenzer, J
    ANNALS OF NEUROLOGY, 2003, 54 : S151 - S151
  • [45] Enzyme replacement therapy for Mucopolysaccharidosis Type I among patients followed within the MPS Brazil Network
    Dornelles, Alicia Dorneles
    Pinto, Louise Lapagesse de Camargo
    de Paula, Ana Carolina
    Steiner, Carlos Eduardo
    Lourenco, Charles Marques
    Kim, Chong Ae
    Gandelman Horovitz, Dafne Dain
    Ribeiro, Erlane Marques
    Valadares, Eugenia Ribeiro
    Goulart, Isabela
    Neves de Souza, Isabel C.
    da Costa Neri, Joao Ivanildo
    Santana-da-Silva, Luiz Carlos
    Silva, Luiz Roberto
    Ribeiro, Marcia
    de Oliveira Sobrinho, Ruy Pires
    Giugliani, Roberto
    Doederlein Schwartz, Ida Vanessa
    GENETICS AND MOLECULAR BIOLOGY, 2014, 37 (01) : 23 - 29
  • [46] Impact of the Timing of Enzyme Replacement Therapy Initiation and Cognitive Impairment Status on Outcomes for Patients with Mucopolysaccharidosis II (MPS II) in the United States: A Retrospective Chart Review
    Yee, Karen S.
    Alexanderian, David
    Feng, Yidie
    Ren, Xiaowei
    Schweikert, Bernd
    Ayodele, Olulade
    JOURNAL OF HEALTH ECONOMICS AND OUTCOMES RESEARCH, 2022, 9 (02): : 67 - 76
  • [47] DNA damage in leukocytes from pretreatment mucopolysaccharidosis type II patients; protective effect of enzyme replacement therapy
    Filippon, Leticia
    Wayhs, Carlos A. Y.
    Atik, Diana M.
    Manfredini, Vanusa
    Herber, Silvani
    Carvalho, Clarissa G.
    Schwartz, Ida V. D.
    Giugliani, Roberto
    Vargas, Carmen R.
    MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 2011, 721 (02) : 206 - 210
  • [48] COMBINED ALLOGENEIC BONE MARROW TRANSPLANTATION AND INTRACEREBROVENTRICULAR ENZYME REPLACEMENT THERAPY FOR PATIENTS WITH NEURONOPATHIC MUCOPOLYSACCHARIDOSIS TYPE II
    Sakaguchi, Hirotoshi
    So, Tetsumin
    Kosuga, Motomichi
    Gocho, Yoshihiro
    Ikenobe, Norito
    Itakura, Yosuke
    Minato, Sonoko
    Morita, Mari
    Fujimori, Kentaro
    Matsui, Toshihiro
    Shimizu, Soichiro
    Yasue, Shiho
    Toyohara, Miwako
    Wada, Yasunori
    Sasahara, Yoji
    Kato, Motohiro
    Deguchi, Takao
    Iguchi, Akihiro
    Tomizawa, Daisuke
    Okuyama, Torayuki
    Matsumoto, Kimikazu
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 84 - 85
  • [49] ANTI-IDURSULFASE ANTIBODY AND THE EFFICACY OF ENZYME REPLACEMENT THERAPY IN THE PATIENTS WITH MUCOPOLYSACCHARIDOSIS II
    Tanaka, A.
    Hamazaki, T.
    Sawada, T.
    Kadono, C.
    Kudo, S.
    Shintaku, H.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2012, 35 : S84 - S84
  • [50] Natural history of valve disease in patients with mucopolysaccharidosis II and the impact of enzyme replacement therapy
    Kampmann, Christoph
    Lampe, Christina
    Wiethoff, Christiane M.
    Arash-Kaps, Laila
    Mengel, Eugen
    Reinke, Joerg
    Beck, Michael
    Hennermann, Julia B.
    Abu-Tair, Tariq
    JOURNAL OF INHERITED METABOLIC DISEASE, 2025, 48 (01)
12345